LANGUAGE 
TOPCOMPANY
COMPANY
ABOUT US
Bionutrion is developing a digital therapeutics to manage Metabolic dysfunction
Associated Steatotic Liver Disease (MASLD) using personalized nutrition
prescription and AI-based cognitive behavioral coaching programs.
The Dr.Coach app, which will be introduced for the first time
as a digital therapeutics for MASLD in Korea, can systematically perform
risk assessment, customized nutrition assessment,
and 1:1 cognitive behavioral coaching for fatty liver disease.
We also adopts food as a medicine,
using Green Protake as a medicine for a short time as a tool to make
you healthier supported by evidence based researches.
VISION / MISSION
VISION / MISSION
VISION
Healthier You Through
Our Life Changing Metabolic Care
Healthier You Through
Our Life Changing Metabolic Care
MISSION
Bionutrion is
the premier life science solution for the prevention and management of metabolic disease on the planet.
OUR TECHNOLOGY
Clinical Trial Report
| Study title | Effectiveness and safety of high protein meal replacements among people with obesity, a Randomized Controlled Trial |
|---|---|
| Study period | Total of 48 weeks |
CORE VALUE
Core Value
-
PATIENT-CENTERED
Improving quality of life
through personalized, holistic care -
INNOVATION
Innovation through continuous research
and science based evidences -
SUSTAINABILITY
Connection to sustainable, healthy eating that benefits the Earth and You
-
COMMUNICATION EXPERT
The ability to believe in and bring out the best in people
-
DIVERSITY & INCLUSION
Growth through inclusion of diverse people
-
EDUCATION & PROMOTION
Trust through transparent communication and high ethical standards
OUR HISTORY
How we got here
-
2025.11
MOU Signing with Carryhill F&B Co., Ltd.
-
2025.10
Recipient of the 2025 2nd Half Innovation Patent Technology Grand Prize, awarded by JoongAng Ilbo
-
2025.9
MOU Signing with Prometa Bio Co., Ltd.
-
2025.8
Certified by the Ministry of Food and Drug Safety (MFDS) for Compliance with Software Medical Device GMP
-
2025.8
Selected for the IP-R&D Strategic Support Program
-
2025.7
Selected as a KISTI Family Company
-
2025.6
Launch of the liquid protein drink, "Gold Protake"
-
2025.6
MOU Signing with SUPREMETECH, MOU Signing with CETNETWORK-ID, and MOU Signing with iCity Vietnam
-
2025.6
Selected for the 2025 Regional Digital Global Bridge
-
2025.6
MOU Signing between LogMe Co., Ltd. and Pharmkit Co., Ltd.
-
2025.4
MOU Signing with Hanyang Institute of Future Medical Science and Technology
-
2025.4
Selected for the Hospital-Based Medical Data Utilization Support Project
-
2025.4
Selected for the Early Harvest Program of the [2025 Digital Healthcare Service Commercialization Promotion Project]
-
2024.12
Certification as a Family-Friendly Workplace
-
2024.10
Our research on obesity management using an ultra-low-calorie diet program has been published in Frontiers in Nutrition (IF 4.0)
-
2024.8
Our joint study with Seoul Bumin Hospital, titled “Effects of a Mobile Lifestyle Intervention Utilizing High-Protein Meal Replacements on Liver Function in Patients with Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD),” has been accepted for publication in a peer-reviewed nutrition journal.
-
2024.3
Selected for the IP-R&D Strategic Support Project
-
2024.1
MOU Signing with Pharmkit Co., Ltd.
-
2023.10
Launched Slimlite as a diet meal replacement for weight control
-
2023.06
Selected for NIPA digital healthcare demonstration project in cooperation with Bumin Hospital
-
2023.05
Selected as a Data Voucher Project, selected as a Startup Voucher project, and won the Women's Business Startup Awards
-
2023.04
Selected as an Agri-Food Venture Incubation project
-
2023.03
Invested USD 800,000 from Big Move Ventures
-
2023.02
Planning to develop a check-up version of the Dr.Coach app
-
2022.10
Completed a Phase 3 trial of a high protein meal replacements, hired a clinical dietitian, and made progress toward licensure of a digital therapeutics
-
2022.09
Planning an update to the Dr.Coach app
-
2022.06
Signed Memorandom Of Understanding with the EZCareTech, medical information company
-
2022.05
Ulsan Angel Investment Matching Fund invested 500 million won, signed sales contract with LohasMedi Corp.
-
2022.04
Signed Exclusive Right to implement patent with Seoul National University Bundang Hospital
-
2022.01
Approval of corporate affiliated labs, venture company certification
-
2021.08
First investment of USD 200,000 from Medytox Ventures, Started Dr. Coach app development
-
2021.05
Signed Memorandom of Understanding between Waycen, AI based healthcare company and BTiwoom, IT company
PARTNERSHIP
